Safety, Tolerability, Kinetics, and Repeatability of the Novel LPA1 PET Ligand 18F-BMS-986327

Conditions

Diseases of the Lung | Diseases of the Respiratory Systems

Phase I

Volunteers
Health Professionals

What is the purpose of this trial?

Brief Summary:

A study to evaluate Safety,Tolerability, Kinetics, and Repeatability of the Novel Lysophosphatidic Acid Receptor 1 (LPA1) Positron Emission Tomography (PET) Ligand 18F-BMS-986327.

Ages
18 years and older
Gender
Both

Find out more about who can participate in this trial

Trial with
Bristol-Myers Squibb Research and Development
Start Date
10/01/2019
End Date
12/31/2020

For more information about this study, contact:

Louis McLellan

I'm interested in volunteering

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 877.978.8343

Volunteer Now

Principal Investigator

Richard Carson, PhD
Professor of Radiology and Biomedical Imaging and of Biomedical Engineering; Director, Yale PET Center; Director of Graduate Studies, Biomedical Engineering

Sub-Investigators

Last Updated
07/15/2021
Study HIC
#2000026009

Safety, Tolerability, Kinetics, and Repeatability of the Novel LPA1 PET Ligand 18F-BMS-986327

Conditions

Volunteers

Health Professionals

What is the purpose of this trial?

I'm interested in volunteering

Principal Investigator

Sub-Investigators

Contact Information